BIESF
Price
$32.00
Change
+$1.52 (+4.99%)
Updated
Mar 10 closing price
Capitalization
1.62B
BSFAF
Price
$0.02
Change
-$0.02 (-50.00%)
Updated
Mar 24 closing price
Capitalization
2.25M
Ad is loading...

BIESF vs BSFAF

Header iconBIESF vs BSFAF Comparison
Open Charts BIESF vs BSFAFBanner chart's image
Biotest AG
Price$32.00
Change+$1.52 (+4.99%)
Volume$100
Capitalization1.62B
BSF Enterprise
Price$0.02
Change-$0.02 (-50.00%)
Volume$10K
Capitalization2.25M
BIESF vs BSFAF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIESF vs. BSFAF commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIESF is a Hold and BSFAF is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (BIESF: $32.00 vs. BSFAF: $0.02)
Brand notoriety: BIESF and BSFAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIESF: 72% vs. BSFAF: 142%
Market capitalization -- BIESF: $1.62B vs. BSFAF: $2.25M
BIESF [@Biotechnology] is valued at $1.62B. BSFAF’s [@Biotechnology] market capitalization is $2.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIESF’s FA Score shows that 2 FA rating(s) are green whileBSFAF’s FA Score has 1 green FA rating(s).

  • BIESF’s FA Score: 2 green, 3 red.
  • BSFAF’s FA Score: 1 green, 4 red.
According to our system of comparison, BIESF is a better buy in the long-term than BSFAF.

Price Growth

BIESF (@Biotechnology) experienced а 0.00% price change this week, while BSFAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
BIESF($1.62B) has a higher market cap than BSFAF($2.25M). BIESF YTD gains are higher at: 4.987 vs. BSFAF (-50.000). BIESF has higher annual earnings (EBITDA): 88.9M vs. BSFAF (-1.68M). BIESF has more cash in the bank: 37.8M vs. BSFAF (1.37M). BIESF has higher revenues than BSFAF: BIESF (707M) vs BSFAF (67.2K).
BIESFBSFAFBIESF / BSFAF
Capitalization1.62B2.25M71,943%
EBITDA88.9M-1.68M-5,305%
Gain YTD4.987-50.000-10%
P/E Ratio42.94N/A-
Revenue707M67.2K1,052,083%
Total Cash37.8M1.37M2,751%
Total DebtN/A118K-
FUNDAMENTALS RATINGS
BIESF: Fundamental Ratings
BIESF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFQIX6.340.08
+1.28%
Janus Henderson Global Equity Income I
RTOUX35.270.33
+0.94%
Russell Inv Tax-Managed US Mid&Sm Cap M
GMNAX9.830.04
+0.41%
Gabelli Global Mini Mites A
JPIVX28.590.11
+0.39%
JPMorgan U.S. Applied Data Sci Val I
GLVNX67.880.01
+0.01%
Invesco Global Focus R

BIESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIESF has been closely correlated with BSFAF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIESF jumps, then BSFAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIESF
1D Price
Change %
BIESF100%
N/A
BSFAF - BIESF
82%
Closely correlated
N/A
SOLTF - BIESF
35%
Loosely correlated
N/A
YECO - BIESF
26%
Poorly correlated
N/A
NMRA - BIESF
23%
Poorly correlated
+2.67%
APLM - BIESF
21%
Poorly correlated
+1.02%
More

BSFAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSFAF has been closely correlated with BIESF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSFAF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSFAF
1D Price
Change %
BSFAF100%
N/A
BIESF - BSFAF
82%
Closely correlated
N/A
SOLTF - BSFAF
29%
Poorly correlated
N/A
YECO - BSFAF
24%
Poorly correlated
N/A
APLM - BSFAF
21%
Poorly correlated
+1.02%
CERO - BSFAF
21%
Poorly correlated
+3.35%
More